SCHEMBL18718185

SCHEMBL18718185

CCCC(C)(C)Cc1cccc(C(=O)Nc2cccc(C)c2)c1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.63
▸ KMT2A Q03164 4/20 0.63
▸ RXFP1 Q9HBX9 1/20 0.63
▸ KCNK3 O14649 12/20 0.59
▸ KCNK9 Q9NPC2 10/20 0.59
▸ KCNH2 Q12809 1/20 0.59
▸ RAB9A P51151 3/20 0.56
▸ HTT P42858 1/20 0.56
▸ POLB P06746 1/20 0.56
▸ THRB P10828 1/20 0.54
▸ LMNA P02545 1/20 0.53
▸ NR1H4 Q96RI1 1/20 0.50
▸ FFAR1 O14842 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ GLA P06280 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1690508 0.88 MEN1 (0.68) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL1696311 0.84 MEN1 (0.70) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL15676738 0.84 MEN1 (0.74) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL17052993 0.80 MEN1 (0.72) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL4253897 0.79 KCNK3 (0.93) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL18718041 0.77 NPC1 (0.56) MEN1KMT2ARAB9ALMNATP53
SCHEMBL21377635 0.77 KCNK3 (0.77) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL1690509 0.76 NPC1 (0.57) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL20064059 0.76 KCNK3 (0.77) MEN1KMT2ARXFP1KCNK3KCNK9
SCHEMBL18717450 0.76 LOXL2 (0.59) MEN1KMT2ARAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9617224-B2 Five-membered heterocycles useful as serine protease inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-04-11 — — US disclosed
Send feedback